May 21
|
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
|
May 20
|
Pulsed field ablation poised for fast adoption, analysts say
|
May 20
|
Johnson & Johnson's Dividend Analysis
|
May 20
|
J&J posts latest Varipulse data while awaiting FDA review
|
May 15
|
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
|
May 14
|
Is Ardagh Metal Packaging SA (NYSE:AMBP) the Best High-Dividend Penny Stock to Buy Now?
|
May 14
|
Is B2Gold Corp (NYSE:BTG) the Best High-Dividend Penny Stock to Buy Now?
|
May 14
|
Funds Linked to Morgan Stanley, Blue Owl Join Bond Sales Blitz
|
May 14
|
Q1 2024 Stereotaxis Inc Earnings Call
|
May 13
|
Johnson & Johnson's Subsidiary Discontinues Some Megadyne Electrodes For Pediatric Use
|
May 13
|
Top Midday Stories: Return of 'Roaring Kitty' Lifts GameStop Shares; Intel, Apollo Near Deal on Ireland Plant; BHP Latest Offer Rejected by Anglo American; Squarespace Acquired by Permira; Amazon Autonomous Driving Under Probe
|
May 13
|
14 Best Long-Term Dividend Stocks To Buy Now
|
May 13
|
Johnson & Johnson (JNJ) Could Be a Great Choice
|
May 13
|
Takeda shells out $100m to license AC Immune’s Phase II Alzheimer’s therapy
|
May 13
|
Johnson & Johnson to sell remaining stake in Kenvue
|
May 13
|
Sector Update: Consumer Stocks Gain Premarket Monday
|
May 13
|
2 Supercharged Dividend Stocks to Buy and Hold for Years
|
May 13
|
We Think Johnson & Johnson (NYSE:JNJ) Can Stay On Top Of Its Debt
|
May 13
|
J&J to exit spinoff Kenvue with latest stake sale
|
May 13
|
J&J’s Megadyne discontinues pediatric electrode pad after burn reports
|